Literature DB >> 19059618

Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail.

Ajay K Bhatia1, Rajnish Kaushik, Nancy A Campbell, Suzanne E Pontow, Lee Ratner.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) matrix (MA) domain is involved in both early and late events of the viral life cycle. Simultaneous mutation of critical serine residues in MA has been shown previously to dramatically reduce phosphorylation of MA. However, the role of phosphorylation in viral replication remains unclear. Viruses harboring serine to alanine substitutions at positions 9, 67, 72, and 77 are severely impaired in their ability to infect target cells. In addition, the serine mutant viruses are defective in their ability to fuse with target cell membranes. Interestingly, both the fusion defect and the infectivity defect can be rescued by truncation of the long cytoplasmic tail of gp41 envelope protein (gp41CT). Sucrose density gradient analysis also reveals that these mutant viruses have reduced levels of gp120 envelope protein incorporated into the virions as compared to wild type virus. Truncation of the gp41CT rescues the envelope incorporation defect. Here we propose a model in which mutation of specific serine residues prevents MA interaction with lipid rafts during HIV-1 assembly and thereby impairs recruitment of envelope to the sites of viral budding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059618      PMCID: PMC2651518          DOI: 10.1016/j.virol.2008.10.047

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  74 in total

1.  Entropic switch regulates myristate exposure in the HIV-1 matrix protein.

Authors:  Chun Tang; Erin Loeliger; Paz Luncsford; Isaac Kinde; Dorothy Beckett; Michael F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

2.  Myristoylation-dependent replication and assembly of human immunodeficiency virus 1.

Authors:  M Bryant; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Human immunodeficiency virus pseudotypes with expanded cellular and species tropism.

Authors:  D H Spector; E Wade; D A Wright; V Koval; C Clark; D Jaquish; S A Spector
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  The pH independence of mammalian retrovirus infection.

Authors:  M O McClure; M A Sommerfelt; M Marsh; R A Weiss
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

5.  Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range.

Authors:  N R Landau; K A Page; D R Littman
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.

Authors:  Jayanta Bhattacharya; Paul J Peters; Paul R Clapham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion.

Authors:  S E Pontow; N Vander Heyden; S Wei; L Ratner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.

Authors:  Akira Ono; Eric O Freed
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.

Authors:  Donald J Wyma; Jiyang Jiang; Jiong Shi; Jing Zhou; Janet E Lineberger; Michael D Miller; Christopher Aiken
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication.

Authors:  Rajnish Kaushik; Lee Ratner
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more
  14 in total

1.  Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.

Authors:  August O Staubus; Ayna Alfadhli; Robin Lid Barklis; Eric Barklis
Journal:  Virology       Date:  2019-09-18       Impact factor: 3.616

2.  Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate.

Authors:  Kazuaki Monde; Vineela Chukkapalli; Akira Ono
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Intra-spike crosslinking overcomes antibody evasion by HIV-1.

Authors:  Rachel P Galimidi; Joshua S Klein; Maria S Politzer; Shiyu Bai; Michael S Seaman; Michel C Nussenzweig; Anthony P West; Pamela J Bjorkman
Journal:  Cell       Date:  2015-01-29       Impact factor: 41.582

Review 4.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

5.  Enhanced antagonism of BST-2 by a neurovirulent SIV envelope.

Authors:  Kenta Matsuda; Chia-Yen Chen; Sonya Whitted; Elena Chertova; David J Roser; Fan Wu; Ronald J Plishka; Ilnour Ourmanov; Alicia Buckler-White; Jeffrey D Lifson; Klaus Strebel; Vanessa M Hirsch
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

6.  HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.

Authors:  Blandine Monel; Elodie Beaumont; Daniela Vendrame; Olivier Schwartz; Denys Brand; Fabrizio Mammano
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

Review 7.  Strategies to inhibit viral protein nuclear import: HIV-1 as a target.

Authors:  Aviad Levin; Abraham Loyter; Michael Bukrinsky
Journal:  Biochim Biophys Acta       Date:  2010-08-16

8.  Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.

Authors:  Ayna Alfadhli; August O Staubus; Philip R Tedbury; Mariia Novikova; Eric O Freed; Eric Barklis
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

9.  Few and far between: how HIV may be evading antibody avidity.

Authors:  Joshua S Klein; Pamela J Bjorkman
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

10.  Deletions in the fifth alpha helix of HIV-1 matrix block virus release.

Authors:  Bridget Sanford; Yan Li; Connor J Maly; Christian J Madson; Han Chen; You Zhou; Michael Belshan
Journal:  Virology       Date:  2014-09-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.